Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test

Mutagenesis

Volumn 14, Issue 1, 1999, Pages 5-22

  Honma, Masamitsu ^a   Hayashi, Makoto ^a   Shimada, Hiroyasu ^b   Tanaka, Noriho ^c   Wakuri, Shinobu ^c   Awogi, Takumi ^d   Yamamoto, Koichi I ^e   Kodani, Noriko Ushio ^e   Nishi, Yoshisuke ^f   Nakadate, Masahiro ^a   Sofuni, Toshio ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c HATANO RESEARCH INSTITUTE   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^e TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^f JAPAN TOBACCO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; POISON; SOLVENT; THYMIDINE KINASE; TRIFLURIDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY TEST; GENE LOCUS; GENE MUTATION; GENOTOXICITY; JAPAN; LEUKEMIA L 5178 Y; MOUSE; MUTAGENICITY; MUTANT; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REVERTANT; SPINDLE CELL;

ANIMALS; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; EVALUATION STUDIES; LEUKEMIA L5178; MICE; MUTAGENICITY TESTS; MUTAGENS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032949360     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.1.5     Document Type: Article

References (107)

1. Aaron, C.S., Bolcsfoldi, G., Glatt, H.R., Moore, M., Nishi, Y., Stankowski, L., Jr, Theiss, J. and Thompson, E. (1994) Mammalian cell gene mutation assays working group report. Mutat. Res., 312, 235-239.
2. Amacher, D.E. and Turner, G.N. (1982) Mutagenic evaluation of carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liver. Mutat. Res., 97, 49-65.
3. Amacher, D.E. and Zelljadt, I. (1984) Mutagenic activity of some clastogenic chemicals at the hypoxanthine guanine phosphoribosyl transferase locus of Chinese hamster ovary cells. Mutat. Res., 136, 137-145.
4. Anderson, D. and Styles, J.A. (1978) The bacterial mutation test. Br. J. Cancer, 37, 924-930.
5. Anderson, B.E., Zeiger, E., Shelby, M.D., Resnick, M.A., Gulati, D.K., Ivett, J.L. and Loveday, K.S. (1990) Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ. Mol. Mutagen., 18, 55-137.
6. Ando, N., Nakajima, T., Masuda, H., Kawabata, Y., Iwai, M., Watanabe, M., Kagitani, Y., Yamada, N. and Tsukagoshi, S. (1995) Antimicrotuble effects of the novel antitumor benzoylphenylurea derivative HO-221. Cancer Chemother. Pharmacol., 37, 63-69.
7. Ashby, J. and Paton, D. (1993) The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposure. Mutat. Res., 286, 3-74.
8. Ashby, J., de Serres, F.J., Draper, M., Ishidate, M., Jr, Margolin, B.H., Matter, B.E. and Shelby, M.D. (1985) Evaluation of Short-Term Tests for Carcinogens, Vol. 5. Elsevier, Amsterdam, The Netherlands.
9. Bartsch, H. et al. (1980) Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolic systems. Mutat. Res., 76, 1-50.
10. Bean, C.L., Armstrong, M.J. and Galloway, S.M. (1992) Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat. Res., 265, 31-44.
11. Blazak, B.F., Los, F.J., Rudd, C.J. and Caspary, W.J. (1989) Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control culture. Mutat. Res., 224, 197-208.
12. Bruce, W.R. and Heddle, J.A. (1979) The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assay. Can. J. Genet. Cytol., 21, 319-333.
13. Caldwell, J. (1993) Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens. Teratogen. Carcinogen. Mutagen., 13, 185-190.
14. Caspary, W., Langenbach, R., Penman, B.W., Crespi, C., Myhr, B.C. and Mitchell, A.D. (1988) The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells. Mutat. Res., 196, 61-81.
15. CEC/EU (1989) The Rules Governing Medicinal Products in the European Community, Vol. III. Guidelines on the Quality, Safety and Efficacy of Medical Products for Human Use. Commission of the European Communities, Brussels, Belgium, p. 103.
16. Chetelat, A. (1987) Hoffman-La Roche Research Report no. B-153′750. Hoffman-La Roche, Zurich, Switzerland.
17. Clay, P. and Cross, M.F. (1990) Microwell mutation assays: evaluation of ethylmethanesulfonate, benzo[a]pyrene and benzidine using the tk locus in L5178Y mouse lymphoma cells. Mutagenesis, 5 (suppl.), 45-54.
18. Clive, D. and Spector, J.F.S. (1975) Laboratory procedure for assessing specific locus mutations at the Tk locus in cultured L5178Y mouse lymphoma cells. Mutat. Res., 31, 17-29.
19. Clive, D., Johnson, K.O., Spector, J.F.S., Batson, A.G. and Brown, M.M.M. (1979) Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res., 59, 61-108.
20. Clive, D., Turner, N.T., Krehl, R. and Eyre, J. (1985) The mouse lymphoma assay may also be used as a chromosome aberration assay. Environ. Mutagen., 7, 33.
21. Clive, D., Glover, P., Applegate, M. and Hozier, J. (1990) Molecular aspects of chemical mutagenesis in L5178Y/tk+/- mouse lymphoma cells. Mutagenesis, 5, 191-197.
22. Clive, D., Bolcsfoldi, G., Clements, J., Cole, J., Honma, M., Majeska, J., Moore, M., Muller, L., Myhr, B., Oberly, T., Odelhkim, M.C., Rudd, C., Shimada, H., Sofuni, T., Thyband, V. and Wilcox, P. (1995) Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 165-168.
23. Cole, J., Arlett, C.F. Green, M.H.L., Lowe, J. and Muriel, W. (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat. Res., 111, 371-386.
24. Cole, J., McGregor, D.B., Fox, M., Thacker, J. and Garner, R.C. (1990) Gene mutation assays in cultured mammalian cells. In Kirkland, D.J (ed.), Basic Mutagenicity Test: UKEMS Recommended Procedures. Cambridge University Press, Cambridge, UK, pp. 87-114.
25. Cole, J., Richmond, F.N. and Bridges, B.A. (1991) The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk+/- mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei. Mutat. Res., 253, 55-62.
26. Combes, R.D., Stopper, H. and Caspary, W.J. (1995) The use of L5178Y mouse lymphoma cells to asses the mutagenic, clastogenic and aneugenic properties of chemicals. Mutagenesis, 10, 403-408.
27. Dearfield, K.L. (1989) Potential EPA/OPP mutagenicity testing requirements - guidelines revisions. Environ. Mol. Mutagen., 14, 47.
28. Dearfield, K.L., Auletta, A.E., Cimino, M.C. and Moore, M.M. (1991) Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat. Res., 258, 259-283.
29. DHSS UK (1989) Guidelines for Testing Chemicals for Mutagenicity. DHSS Report on Health and Social Subjects no. 35. HMSO, London, UK.
30. Dickins, M., Wright, K., Phillips, M. and Todd, N. (1985) Toxicity and mutagenicity tests of 4 anti-cancer drugs in cultured Chinese hamster cells. Mutat. Res., 143, 149-154.
31. Dunkel, V.C., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortelmans, K. and Simmon, V.F. (1985) Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Esherrichia coli. Environ. Mutagen., 7 (suppl. 5), 1-248.
32. Federal Register (1993) Draft Revised Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. FDA/CFSAN, Washington, D.C., USA.
33. Furth, E.M., Thilly, W.G., Penman, B.A., Liber, H.L. and Rand, W.M. (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal. Biochem., 110, 1-8.
34. Galloway, S.M., Armstrong, M.J., Reuben, C., Colman, S., Brown, B.C.C., Bloom, A.D., Nakamura, F., Ahmed, M., Duk, S., Rimpo, J., Margolin, B.H., Resnick, M.A., Anderson, B. and Zeiger, E. (1987) Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environ. Mol. Mutagen., 10, 1-175.
35. Garberg, P., Akerblom, E.-L. and Bolcsfoldi, G. (1988) Evaluation of a genotoxicity test measuring DNA-strand breaks in mouse lymphoma cells by unwinding and hydroxyapatite elution. Mutat. Res., 203, 155-176.
36. Garriot, M.L., Casciano, D.A., Schechtman, L.M. and Probst, G.S. (1995) International workshop on mouse lymphoma assay testing practices and data interpretations: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 162-164.
37. Gatehouse, D.G., Stemp, G., Pascoe, S., Wilcox, P., Hawker, J. and Tweats, D.J. (1991) Investigation into the induction of aneuploidy and polyploidy in mammalian cells by the anti-tussive agent noscapine hydrochloride. Mutagenesis, 6, 279-283.
38. Hashimoto, T., Negishi, T., Namba, T., Hayakawa, S. and Hayatsu, H. (1979) Mutagenicity of quinoline derivatives and analogs - quinoxaline 1,4-dioxide is a potent mutagen. Chem. Pharm. Bull., 27, 219-224.
39. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W. and Zeiger, E. (1983) Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen., 5 (suppl. 1), 3-142.
40. Heddle, J.A. and Bruce, W.R. (1977) On the use of multiple assays for mutagenicity, especially the micronucleus. Salmonella, and sperm abnormality assays. In Scott, D., Bridges, B.A. and Sobels, F.H. (eds). Progress in Genetic Toxicology. Elsevier/North-Holland, Amsterdam, The Netherlands, pp. 265-274.
41. Honma, M., Hayashi, M., Hackman, P. and Sofuni, T. (1997) Chlorambucil-induced structural changes in the gpt gene of AS52 cells. Mutat. Res., 389, 199-205.
42. Honma, M., Zhang, L.-S., Sakamoto, H., Ozaki, M., Takeshita, K., Momose, M., Hayashi, M. and Sofuni, T. (1999) The need for long-term treatment in the mouse lymphoma assay. Mutagenesis, 14, 23-29.
43. +/--3.7.2C cell line. Mutat. Res., 105, 451-456.
44. ICH (1994) Technical symposium: Safety, Session 1: Harmonization of genotoxicity testing requirements. In D'Arcy, P.F. and Harron, D.W.G. (eds), Proceedings of the Second International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Orlando 1993. The Queen's University, Belfast, UK, pp. 221-257.
45. ICH (1996) Technical symposium: Safety, Session 4: Genotoxicity testing. In D'Arcy, P.F. and Harron, D.W.G. (eds), Proceedings of the Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Yokohama, 1995. The Queen's University, Belfast, pp. 303-329.
46. Ishidate, M., Jr (1987) Data Book of Chromosome Aberration Test In Vitro. LIC/Elsevier, Tokyo, Japan.
47. Ishidate, M., Jr (1988) A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutat. Res., 205, 397-407.
48. Ishidate, M., Jr (1991) Data Rook of Bacterial Mutagenicity Test (in Japanese). LIC, Tokyo, Japan.
49. Ivett, J.L., Brown, B.M., Rodgers, C., Anderson, B.E., Resnick, M.A. and Zeiger, E. (1989) Chromosomal aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. IV. Results with 15 chemicals. Environ. Mol. Mutagen., 14, 165-187.
50. Jacobson-Kram, D. and Montalbano, D. (1985) The Reproductive Effects Assessment Group's report on the mutagenicity of inorganic arsenic. Environ. Mutagen., 7, 787-804.
51. Jotz, M.M. and Mitchell, A.D. (1981) Effect of 20 coded chemicals on the forward mutation frequency at the thymidine kinase locus in L5178Y mouse lymphoma cells. Prog. Mutat. Res., 1, 580-593.
52. Larizza, L., Simoni, G., Tredici, F. and DeCarli, L. (1974) Griseofulvin: a potent agent of chromosomal segregation in cultured cells. Mutat. Res., 25, 123-130.
53. Leung, H.-W. (1994) Evaluation of the genotoxic potential of alkyleneamines. Mutat. Res., 320, 31-43.
54. Li, A.P., Aaron, C.S., Auletta, A.E., Dearfield, K.L., Riddle, J.C., Slesinski, R.S. and Stankowski, L.F., Jr (1991) An evaluation of the roles of mammalian cell mutation assays in the testing of chemical genotoxicity. Regul. Toxicol. Pharmacol., 14, 24-40.
55. Majeska, J.B. and Matheson, D.W. (1990) Development of an optimal S9 activation mixture for the L5178YTK+/- mouse lymphoma mutation assay. Environ. Mol. Mutagen., 16, 311-319.
56. Marzin, D.R. and Phi, H.V. (1985) Study of the mutagenicity of metal derivatives with Salmonella typhimurium TA102. Mutat. Res., 155, 49-51.
57. Matsuoka, A., Yamakage, K., Kusakabe, H., Wakuri, S., Asakura, M., Noguchi, T., Sugiyama, T., Shimada, H., Nakayama, S., Kasahara, Y., Takahashi, Y., Miura, K.F., Hatanaka, M., Ishidate, M., Jr, Morita, T., Watanabe, K., Hara, M., Odawara, K., Tanaka, N., Hayashi, M. and Sofuni, T. (1996) Re-evaluation of chromosomal aberration induction on nine mouse lymphoma assay 'unique positive' NTP carcinogens. Mutat. Res., 369, 243-252.
58. McCann, J., Choi, E., Yamasaki, E. and Ames, B. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test, assay of 300 chemicals. Proc. Natl Acad. Sci. USA, 72, 5135-5139.
59. McGregor, D.B., Brown, A., Cattanach, P., Edwards, I., McBride, D. and Caspary, W.J. (1988a) Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals. Environ. Mol. Mutagen., 11, 91-118.
60. McGregor, D.B., Brown, A., Cattanach, P., Edwards, I., McBridge, D., Riach, C. and Caspary, W.J. (1988b) Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. III: 72 coded chemicals. Environ. Mol. Mutagen., 12, 85-154.
61. McGregor, D.B., Brown, A.C., Howgate, S., McBride, D., Riach, C. and Caspary, W.J. (1991) Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. V: 27 coded chemicals. Environ. Mol. Mutagen., 17, 196-219.
62. McGregor, D.B., Brown, A.G., Cattanach, P., Shepherd, W., Riach, C., Daston, D.S. and Caspary, W.J. (1989) TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. Carcinogenesis, 10, 2003-2008.
63. MHW Japan (1990) Guidelines for Toxicity Studies of Drugs Manual. Ministry of Health and Welfare, Tokyo, Japan.
64. +/- mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 394, 177-303.
65. Mondello, C., Giorgi, R. and Nuzzo, F. (1984) Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat. Res., 139, 67-70.
66. Moore-Brown, M.M., Clive, D., Howard, B.E., Batson, A.G. and Johnson, K.O. (1981) The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells. Mutat. Res., 85, 363-378.
67. Moore, M.M. and Clive, D. (1982) The quantitation of TK-/-and HGPRT-mutants of L5178Y/TK+/-mouse lymphoma cells at varying times posttreatment. Environ. Mutagen., 4, 499-519.
68. Moore, M.M. and Howard, B.E. (1982) Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/-mouse lymphoma cells in RPMI-1640 medium. Mutat. Res., 104, 287-294.
69. Moore, M.M., Clive, D., Hozier, J.C., Howard, B.E., Batson, A.G., Turner, N.T. and Sawyer, J. (1985) Analysis of trifluorothymidine-resistant (TFT) mutants of L5178Y/TK+/-mouse lymphoma cells. Mutat. Res., 151, 161-174.
70. Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B. and Zeiger, E. (1986) Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mol. Mutagen., 7, 1-119.
71. Myhr, B.C. and Caspary, W.J. (1988) Evaluation of L5178Y mouse lymphoma cell mutagenesis assay: intralaboratory results for sixty-three chemicals tested at Litton Bionetics, Inc. Environ. Mol. Mutagen., 12, 103-194.
72. Myhr, B.C. and Caspary, W.J. (1991) Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program. Environ. Mol. Mutagen., 18, 51-83.
73. Myhr, B., McGregor, D., Bowers, L., Riach, C., Brown, A.G., Edward, I., McBride, D., Martin, R. and Caspary, W.J. (1990) L5178Y mouse lymphoma cell mutation assay results with 41 compounds. Environ. Mol. Mutagen., 18, 138-167.
74. Nakamuro, K. and Sayoto, Y. (1981) Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat. Res., 88, 73-80.
75. Oberly, T.J., Piper, C.E. and McDonald, D.S. (1982) Mutagenicity of metal salts in the L5178Y mouse lymphoma assay. J. Toxicol. Environ, Health, 9, 367-376.
76. Oberly, T.J., Bewsey, B.J. and Probst G.S. (1984) An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat. Res., 125, 291-306.
77. Oberly, T.J., Michealis, K.C., Rexroat, M.A., Bewsey, B.J. and Garriott, M.L. (1993) A comparison of the CHO/HGPRT+ and L5178Y/TK+/- mutation assays using suspension treatment and soft agar cloning: results for 10 chemicals. Cell Biol. Toxicol., 9, 243-257.
78. O'Donoghue, J.L., Haworth, S.R., Curren, R.D., Kirby, P.E., Lawlor, T., Moran, E.J., Phillips, R.D., Putnam, D.L., Rogers-Back, A.M., Slesinski, R.S. and Thilagar, A. (1988) Mutagenicity studies on ketone solvents: methyl ethyl ketone, methyl isobutyl ketone, and isophorone. Mutat. Res., 206, 149-161.
79. Otsuka, M. et al. (1991) Mutagenicity studies of YK-176. Kiso To Rinsyo, 25, 1311-1320.
80. PDR (1995) Physician's Desk Reference, 71, 2042.
81. Robinson, W.D., Green, M.H.L., Cole, J., Healy, M.J.R., Garner, R.C. and Gatehouse, D. (1989) Statistical evaluation of bacterial/mammalian fluctuation tests. In Kirkland, D.J. (ed.). Statistical Evaluation of Mutugenicity. Cambridge University Press, Cambridge. UK. pp. 102-140.
82. Segawa, M., Nadamitsu, S., Kondo, K. and Yoshizaki, I. (1979) Chromosomal aberration of Don lung cells of Chinese hamster after exposure to vinblastine in vitro. Mutat. Res., 66, 99-102.
83. Seino, Y., Nagao, M., Yahagi, T., Hoshi, A., Kawachi, T. and Sugimura, T. (1978) Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98. TA100, and TA92. Cancer Res., 38, 2148-2156.
84. Sekizawa, J. and Shibamoto, T. (1982) Genotoxicity of safrol-related chemicals in microbial test systems. Mutat. Res., 101, 127-140.
85. Sherwood, S.W., Schumacher, R.T. and Schmke, R.T. (1988) Effect of cycloheximide on development of methotrexate resistance of Chinese hamster ovary cells treated with inhibitors of DNA synthesis. Mol. Cell. Biol., 8, 2822-2827.
86. Shimizu, M., Yasui, Y. and Matsumoto, N. (1983) Structural specificity of aromatic compounds with special reference to mutagenic activity in Salmonella typhimurium - a series of chloro- or fluoro-nitrobenzene derivatives. Mutat. Res., 116, 217-238.
87. Slamenova, D., Budayova, E., Dusinska, M. and Gabelova, G. (1986a) Results of genotoxicity testing of theophylline on bacteria and two lines of mammalian cells. Neoplasma, 33, 457-463.
88. Slamenova, D., Budayova, E., Gabelova, A. and Dusinska, M. (1986b) Prescreening of carcinogens by studying of DNA synthesis inhibition and gene mutations in mammalian cells. Neoplasma, 33, 699-706.
89. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Nishi, Y. and Nakadale, M. (1996) Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: interim report of an international collaborative study. Mutagenesis, 11, 349-355.
90. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Nishi, Y. and Nakadate, M. (1997a) Report of an international collaborative study of the mouse lymphoma assay using the microwell method. Mutat. Res., 379, S191.
91. Sofuni, T., Wilcox, P., Shimada, H., Clements, J., Honma, M., Clive, D., Green, M., Thyband, V., San, R.H.C, Elliott, B.M. and Müller, L. (1997b) Mouse Lymphoma Workshop: Victoria, British Columbia, Canada, March 27, 1996: protocol issues regarding the use of the microwell method of the mouse lymphoma assay. Environ. Mol. Mutagen., 29, 434-438.
92. Suter, W., Brennand, J., McMillan, S. and Fox, M. (1980) Relative mutagenicity of antineoplastic drugs and other alkylating agents in V79 Chinese hamster cells, independence of cytotoxic and mutagenic responses. Mutat. Res., 73, 171-181.
93. Suter, W., Negro, L., Barrera, I., and Schneider, B. (1992) Resistance to Pseudomonas toxin A: a sensitive marker to screen for mutagenic substances using V79 cells. Mutagenesis, 7, 125-135.
94. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewics, S., Anderson, B. and Minor, R. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
95. Tindall, K.R. and Stankowski, L.F. (1987) Deletion mutations are associated with the differential induced mutant frequency response of the AS52 and CHO-KI-BH4 cell lines. In Moore, M.M., DeMarini, D.M., DeSerres, F.J. and Tindall, K.R. (eds). Mammalian Cell Mutagenesis, Banbury Report 28. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY, pp. 283-299.
96. Turner, N.T. Batson, A.J. and Clive, D. (1984) Procedure for the L5178Y/ TK+/-to TK-/-mouse lymphoma cell mutagenicity assay. In Kilbey, B.J., Legator, M., Nichols, W. and Ramel, C. (eds), Handbook of Mutagenicity Test Procedures. Elsevier, Amsterdam, The Netherlands, pp. 239-268.
97. Umeda, M. and Saito, M. (1971) The effect of monocrotaline, a pyrrolizidine alkaloid, on HeLa cells and primary cultured cells from rat liver and lung. Acta. Pathol. Jpn. 21, 507-514.
98. Waskell, L. (1978) A study of the mutagenicity of anesthetics and their metabolites. Mutat. Res., 57, 141-153.
99. Wehner, F.C., Marasas, W.F.O. and Thiel.P.G. (1978a) Lack of mutagenicity to Salmonella typhimurium of some fusarium mycoloxins. Appl. Environ. Microbiol., 35, 659-662.
100. Wehner, F.C., Thiel, P.G., VanRensburg, S.J. and Demasius, I.P.C. (1978b) Mutagenicity to Salmonella typhimurium of some aspergillus and penicillium mycotoxins. Mutat. Res., 58, 193-203.
101. Weinstein, D., Katz, M. and Kazmer, S. (1981) Use of rat/hamster S-9 mixture in the Ames mutagenicity assay. Environ. Mutagen., 3, 1-9.
102. Yajima, N., Kondo, K. and Morita, K. (1981) Reverse mutation tests in Salmonella typhimurium and chromosomal aberration tests in mammalian cells in culture on fluorinated pyrimidine derivatives. Mutat. Res., 88, 241-254.
103. Yamanaka, H., Nagao, M., Sugimura, T., Furuya, T., Shirai, A. and Matsushima.T. (1979) Mutagenicity of pyrrolizidine alkaloids in the Salmonellal mammalian-microsome test. Mutat. Res., 285, 27-33.
104. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., Mortelmans, K. and Speck, W. (1987) Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen., 9, 1-110.
105. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. and Mortelmans, K. (1988) Salmonella mutagenicity tests: results from the testing of 300 chemicals. Environ. Mol. Mutagen., 11, 1-158.
106. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H. and Tennant, R.W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16, 1-14.
107. Zhang, L.-S., Honma, M., Matsuoka, A., Suzuki, T., Sofuni, T. and Hayashi, M. (1996) Chromosome painting analysis of spontaneous and methylmethanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies. Mutat. Res., 370, 181-190.